Cilcare Study to Explore Hearing in Patients with Neurodegenerative DiseasesÂ
The study aims to develop auditory biomarkers for early detection and improved management of Alzheimer’s and Parkinson’s disease.
The study aims to develop auditory biomarkers for early detection and improved management of Alzheimer’s and Parkinson’s disease.
Researchers have identified and mapped diverse cell types in the cochlear nucleus, a critical part of the auditory system, advancing understanding of how our brains process sounds and paving the way for targeted treatments for auditory disorders.
Researchers aim to uncover the causes of acquired hearing loss (AHL) and explore new strategies for its prevention.
A study of veterans suggests a link between hearing loss and risk of Parkinson’s disease, with hearing aids potentially reducing this risk.
Read MoreA randomized trial found that hearing and vision rehabilitation can improve the short-term quality of life for people with dementia.
Read MoreA multisensory solution significantly improves auditory spatial perception in hearing aid users and cochlear implant recipients.
Read MoreStimulating the vagus nerve with electrical pulses may offer applications for enhanced hearing, particularly in cochlear implant users.
Read MoreA PhD student has been recognized as a finalist in the Victorian International Education Awards for his work on hybrid cochlear implants.
Read MoreApproximately 25% of noise-exposed utility workers experience hearing loss, with hydroelectric power generation workers most at risk.
Read MoreData on ear size and shape will be used to enhance hearing aid programming and provide better and safer amplification for individuals.
Read MoreLineage Cell Therapeutics announced promising preclinical results for its auditory neuronal cell transplant designed to treat hearing loss.
Read MoreThe novel drug delivery system uses hydrogels and nanoparticles to protect against hearing loss caused by the chemotherapy drug cisplatin.
Read MoreA researcher received funding from the NIH to research the use of magnetic nanoparticles for drug delivery for hearing loss treatment.
Read MoreThe PROHEAR study is a placebo-controlled Phase 2a study investigating the otoprotective efficacy of ACOU085 in patients with testicular cancer undergoing cisplatin-based chemotherapy.
Read MoreResearchers successfully restored hearing in adult mice with inherited hearing loss by using gene editing to shut down a damaged copy of the MIR96 gene.
Read MoreOticon and Henry Ford Health’s Division of Audiology launched a clinical research partnership to improve hearing aid fittings.
Read MoreThe goal is to attract at least 10,000 participants to explore how hearing training affects skills like speech comprehension and sound localization.
Read MoreSensorion was recommended to continue the study of a drug candidate for the prevention of Cisplatin-Induced Ototoxicity (CIO).
Read More